Tracey Walker, Contributing Editor
New study links e-cigs to conventional cigarette use among teens
E-cigarette use recently doubled among teens, and these teens are also smoking conventional cigarettes.
Researchers find link between oral contraceptives and MS
Researchers have found a link between women who have taken oral contraceptives and an increased risk of multiple sclerosis (MS). However, this does not mean women should stop taking birth control.
Hospital saline shortages trigger pharmacy action plans
Is your hospital ready? The emergency is here.
FDA lifts age restrictions on OTC Plan B morning-after contraceptive
Teen can buy generic morning-after contraceptive directly from OTC shelves without proving age.
Stroke prevention in the elderly may be excessive, researcher says
Patients more than 80 years old are being “over-treated” for stroke prevention with statins and antihypertensive drugs, and doctors need to actively rethink their priorities and beliefs about stroke prevention, according to a new study published in Evidence Based Medicine.
OA treatment for knee pain approved
FDA has approved hyaluronic acid (HA) injection (Monovisc, Anika Therapeutics), a single-injection supplement to synovial fluid of the osteoarthritic joint, for the treatment of pain and the improvement of joint mobility in patients with osteoarthritis (OA) of the knee.
NIH study focuses on safe step-down therapy for asthma
18 research centers are working to establish guidelines for safe step-down procedures for patients with well-controlled asthma.
Seniors on blood-pressure meds have more risk of injury from falls
Blood pressure medications used by many older adults can increase the risk of serious fall injuries by 30% to 40%.
Namenda tablets to be discontinued by Forest Labs
Forest Laboratories plans to discontinue the sale of memantine HCl (Namenda) 5-mg and 10-mg tablets effective August 15, 2014. Forest has notified FDA of this decision.
Treatment for rare metabolic disease approved
FDA approved metreleptin for injection (Myalept, Amylin Pharmaceuticals) as replacement therapy to treat the complications of leptin deficiency, in addition to diet, in patients with congenital generalized or acquired generalized lipodystrophy.


View Results